Maja Stojiljkovic is a full research professor and head of Rare Disease Research and Therapeutics Development group at the Institute of Molecular Genetics and Genetic Engineering, University of Belgrade in Serbia. Her research is focused on genomics of rare diseases, functional characterization of novel genetic variants and discovery of novel molecular therapeutics for rare diseases. Dr Stojiljkovic is coordinator of ORPHANET-Serbia, secretary of ICORD and member of Expert Committee of National Organization for RDs of Serbia. Dr Stojiljkovic is actively involved in genetic testing of rare diseases in Serbia, bringing new technologies and experimental solutions to routine use.
The impact of next-generation sequencing on diagnosis and treatment of rare diseases